# Eddine Saiah

> Eddine Saiah, Ph.D., is the CEO and President of Stablix, a preclinical biotechnology company pioneering targeted protein stabilization (TPS) as a new class of small-molecule medicines. A medicinal chemist and drug hunter with more than 25 years of experience, he joined Stablix as Chief Scientific Officer in 2022 and moved into the chief executive role in 2025. His career spans big pharma research leadership at Pfizer and Wyeth, an entrepreneur-in-residence stint at Atlas Venture, and CSO duties at Navitor Pharmaceuticals. He is a co-inventor and author on more than 120 patents and publications, and has helped advance more than a dozen small-molecule candidates into clinical trials.

- **Role:** CEO and President at Stablix, Inc.
- **Organizations:** Stablix, Inc., Navitor Pharmaceuticals, Atlas Venture, Pfizer, Wyeth, Mayo Clinic
- **Education:** Ph.D. in Chemistry, Paris Sorbonne University / Pierre and Marie Curie University, Postdoctoral training, Mayo Clinic
- **Known for:** Author and co-inventor on more than 120 publications, patents, reviews and presentations, Advanced more than a dozen small-molecule candidates into clinical trials over his career, Helped advance Navitor Pharmaceuticals to clinical stage as CSO

## Career timeline

- **Pfizer / Wyeth era** — Directed drug discovery teams across inflammation, immunology, cardiometabolic and rare disease therapeutic areas
- **Atlas Venture** — Served as entrepreneur in residence, contributing to early-stage company formation
- **Navitor Pharmaceuticals** — Chief Scientific Officer; led research and early development, helped advance the company to clinical stage
- **2022** — Joined Stablix as Chief Scientific Officer
- **2025** — Promoted to CEO and President of Stablix

## Achievements

- Author and co-inventor on more than 120 publications, patents, reviews and presentations
- Advanced more than a dozen small-molecule candidates into clinical trials over his career
- Helped advance Navitor Pharmaceuticals to clinical stage as CSO
- Rose from CSO to CEO of Stablix within roughly three years

## Latest updates

- **2025** — Promoted from Chief Scientific Officer to CEO and President of Stablix

## Links

- Website: https://stablix.com
- LinkedIn: http://www.linkedin.com/in/eddinesaiah
- Twitter/X: https://twitter.com/EddineSaiah

---

Profile page: https://yespress.io/eddine-saiah
Published by YesPress — https://yespress.io
Last updated: 2026-07-17